Phase I trial of nitisinone [SYN118] as adjunctive therapy in patients with advanced Parkinson's disease.

Trial Profile

Phase I trial of nitisinone [SYN118] as adjunctive therapy in patients with advanced Parkinson's disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2010

At a glance

  • Drugs Nitisinone (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Synosia Therapeutics
  • Most Recent Events

    • 29 Sep 2010 Results were presented at the World Parkinson Congress, according to a Synosia media release.
    • 29 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top